Telangana CM KCR put the state on the fast track development in all sectors. BRS government not only practiced the pro-poor schemes but also balanced them with a corporate-friendly environment.
This benefited the entire state of Telangana and Hyderabad city is developing into the most preferred destination on all fronts. It is now the IT Hub and also hailed as the Pharma City. According to the latest, Aurigene Pharmaceutical Services a contract research, development, and manufacturing services organization and a step-down subsidiary of Dr Reddy's Laboratories decided to invest, $ 40 million (about Rs 330 crore) in the new proposed development and manufacturing facility focused on niche areas like therapeutic proteins, antibodies, and viral vectors in the Genome Valley, Hyderabad.
Dr Reddy’s Laboratories chairman Satish Reddy and Aurigene chief executive officer Akil Ravi held discussions with Industries and IT minister KT Rama Rao to discuss the proposed facility. Akil Ravi said "We are grateful to the Government of Telangana for their efforts to develop Telangana and Hyderabad into a leading pharmaceutical and biotechnology hub by bringing together various stakeholders, providing crucial support and infrastructure,"
KTR said "I am delighted that Aurigene has chosen Genome Valley to establish their research and development and manufacturing facility. This investment is aligned with the Government's vision to enhance complex manufacturing at scale. By investing in biotherapeutics discovery, Aurigene has further strengthened Hyderabad's position as a preferred destination for biopharmaceutical research and production,"
